Eleanor N. Fish
1 King's College Circle
Toronto, ON M5S1A8, Canada
Toronto, ON M5S1A8, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies.
Journal: Molecular cancer therapeutics
Published: March 31, 2025
Signaling by Type I Interferons in Immune Cells: Disease Consequences.
Journal: Cancers
Published: March 11, 2024
Safety, Tolerability, Bioavailability, and Biological Activity of Inhaled Interferon-α2b in Healthy Adults: The IN2COVID Phase I Randomized Trial.
Journal: Clinical drug investigation
Published: May 28, 2023
Implications of Non-Specific Effects for Testing, Approving, and Regulating Vaccines.
Journal: Drug safety
Published: March 14, 2023
Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells.
Journal: Cancer research communications
Published: January 04, 2023
Plasma Proteomic Analysis Distinguishes Severity Outcomes of Human Ebola Virus Disease.
Journal: mBio
Published: April 21, 2022
Tribute to Howard Young.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: April 01, 2022
Regulation of IFNα-induced expression of the short ACE2 isoform by ULK1.
Journal: Molecular immunology
Published: December 20, 2021
A cluster randomized trial of interferon ß-1a for the reduction of transmission of SARS-Cov-2: protocol for the Containing Coronavirus Disease 19 trial (ConCorD-19).
Journal: BMC infectious diseases
Published: April 28, 2021
Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms.
Journal: Nature communications
Published: November 24, 2020
Last Updated: 09/26/2026